Ensign Peak Advisors
LMAT icon

Ensign Peak Advisors’s LeMaitre Vascular LMAT Stock Holding History

Ensign Peak Advisors’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$156K Buy
1,621
+150
+10% +$15.4K ﹤0.01% 1486
2026
Q1 		$161K Hold
1,471
– – ﹤0.01% 1412
2025
Q4 		$119K Sell
1,471
-4,850
-77% -$418K ﹤0.01% 1530
2025
Q3 		$553K Sell
6,321
-3,100
-33% -$277K ﹤0.01% 1336
2025
Q2 		$782K Sell
9,421
-2,050
-18% -$171K ﹤0.01% 1387
2025
Q1 		$962K Hold
11,471
– – ﹤0.01% 1272
2024
Q4 		$1.06M Hold
11,471
– – ﹤0.01% 1287
2024
Q3 		$1.07M Hold
11,471
– – ﹤0.01% 1285
2024
Q2 		$944K Hold
11,471
– – ﹤0.01% 1318
2024
Q1 		$761K Sell
11,471
-579
-5% -$35.7K ﹤0.01% 1490
2023
Q4 		$684K Buy
12,050
+650
+6% +$34K ﹤0.01% 1577
2023
Q3 		$621K Hold
11,400
– – ﹤0.01% 1516
2023
Q2 		$767K Hold
11,400
– – ﹤0.01% 1460
2023
Q1 		$587K Buy
11,400
+500
+5% +$24.3K ﹤0.01% 1595
2022
Q4 		$502K Buy
10,900
+3,600
+49% +$169K ﹤0.01% 1618
2022
Q3 		$370K Hold
7,300
– – ﹤0.01% 1611
2022
Q2 		$333K Hold
7,300
– – ﹤0.01% 1631
2022
Q1 		$339K Hold
7,300
– – ﹤0.01% 1711
2021
Q4 		$367K Hold
7,300
– – ﹤0.01% 1739
2021
Q3 		$388K Hold
7,300
– – ﹤0.01% 1670
2021
Q2 		$445K Buy
7,300
+3,600
+97% +$191K ﹤0.01% 1613
2021
Q1 		$180K Buy
3,700
+3,500
+1,750% +$164K ﹤0.01% 1741
2020
Q4 		$8K Buy
+200
New +$7.15K ﹤0.01% 1850

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Ensign Peak Advisors's LMAT Position: Q2 2026 in Review

Ensign Peak Advisors increased its LeMaitre Vascular (LMAT) stake by 10% in Q2 2026, buying an estimated $15.4K and bringing the position to 1,621 shares worth $156K. The position accounts for ﹤0.01% of the portfolio, ranked #1486.

Ensign Peak Advisors first reported a position in LMAT in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.07M in Q3 2024. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Ensign Peak Advisors held 1,621 shares of LeMaitre Vascular worth $156K as of Q2 2026.
  • Ensign Peak Advisors bought 150 LeMaitre Vascular shares in Q2 2026, an estimated $15.4K.
  • LeMaitre Vascular made up ﹤0.01% of Ensign Peak Advisors's portfolio in Q2 2026, its #1486 holding.
  • Ensign Peak Advisors first reported a position in LeMaitre Vascular in Q4 2020 and has held it in 23 quarters since.
  • Ensign Peak Advisors's LeMaitre Vascular position peaked at $1.07M in Q3 2024.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.